Professor
Surgical Oncology Division Chief
Medical School: University of Michigan
Residency: University of South Florida
Surgical Oncology Fellowship: Ohio State University
Board Certified in General Surgery by the American Board of Surgery
Clinical Services
- Surgical Oncology
-
- Hepatobiliary Cancer (liver, gallbladder, bile ducts...) Surgery
- Pancreatic Cancer Surgery
Research Interests
Selected Publications
Goldin SB, Bradner MW, Zervos EE, Rosemurgy AS 2nd. Assessment of pancreatic neoplasms: review of biopsy techniques. J Gastrointest Surg. 2007 Jun;11(6):783-90.
Durkin AJ, Osborne DA, Yeatman TJ, Rosemurgy AS, Armstrong C, Zervos EE. EGF receptor antagonism improves survival in a murine model of pancreaticadenocarcinoma. J Surg Res. 2006 Sep;135(1):195-201. Epub 2006 May 6.
Zervos EE, Osborne D, Boe BA, Luzardo G, Goldin SB, Rosemurgy AS. Prognostic significance of new onset ascites in patients with pancreatic cancer. World J Surg Oncol. 2006 Mar 28;4:16.
Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol. 2006 Apr;13(4):572-81. Epub 2006 Feb 28.
Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, Carey LC, Rosemurgy AS. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg. 2005 Nov;190(5):810-5.
Osborne D, Boe B, Rosemurgy AS, Zervos EE. Twenty-millimeter laparoscopic cholecystectomy: fewer ports results in less pain, shorter hospitalization, and faster recovery. Am Surg. 2005 Apr;71(4):298-302.
Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS. In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg. 2004 Nov;188(5):584-8.
Durkin AJ, Bloomston M, Yeatman TJ, Gilbert-Barness E, Cojita D, Rosemurgy AS, Zervos EE. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors. J Am Coll Surg. 2004 Nov;199(5):724-31.
Rosemurgy AS, Zervos EE, Clark WC, Thometz DP, Black TJ, Zwiebel BR, Kudryk BT, Grundy LS, Carey LC. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004 Jun;239(6):883-9; discussion 889-91.
Bloomston M, Durkin A, Yang I, Rojiani M, Rosemurgy AS, Enkmann S, Yeatman TJ, Zervos EE. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies. Ann Surg Oncol. 2004 Apr;11(4):413-9.
Zervos EE, Rosemurgy AS, Al-Saif O, Durkin AJ. Surgical management of early-stage pancreatic cancer.Cancer Control. 2004 Jan-Feb;11(1):23-31.
Durkin AJ, Bloomston PM, Rosemurgy AS, Giarelli N, Cojita D, Yeatman TJ, Zervos EE. Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro. Am J Surg. 2003 Nov;186(5):431-6.
Desai DC, Zervos EE, Arnold MW, Burak WE Jr, Mantil J, Martin EW Jr. Positron emission tomography affects surgical management in recurrent colorectalcancer patients. Ann Surg Oncol. 2003 Jan-Feb;10(1):59-64.
Bloomston M, Zervos EE, Rosemurgy AS 2nd. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol. 2002 Aug;9(7):668-74. Review.
Zervos EE, Burak WE Jr. Lymphatic mapping in solid neoplasms: state of the art.Cancer Control. 2002 May-Jun;9(3):189-202. Review.
Zervos EE, Badgwell BD, Burak WE Jr, Arnold MW, Martin EW. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery. 2001 Oct;130(4):636-43; discussion 643-4.
Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW. 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res. 2001 May 1;97(1):9-13.
